Articles Survey Shows Bio/Pharma Value Instrumentation for ProductivityIBO Fall Litigation Review: New Suits Span GC to Digital PCR New Pharma, Government, Genomics Labs AnnouncedNew Product at IDWeek: Pheno’s PhenoTest BC Kit for Personalized Antibiotic Therapy Executive Briefing QIAGEN Names New CEO and Discontinues NGS SystemIllumina and QIAGEN Partner for NGS IVDsMilliporeSigma Expands Cell Therapy OfferingsBruker Expands […]
A look back at 2018 and forward to 2019
New research and manufacturing sites for chemical, pharma, government and academic organizations announced
Danaher takes on bioprocess supplier leaders
New testing requirements as product demand changes
Federal agencies receive budget boosts for FY2019
NHS England, Australian Parkinson’s Mission among organizations receiving new funding
Company sets its sights on the future
Recurring revenues, new markets and operational changes highlighted
The 2019 Annual Review and Forecast Issue is now available here!
October 11, 2021 6:11 pm
September 3, 2021 2:36 pm
August 6, 2021 8:09 pm
Your Data and Privacy
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.